Company intelligence / Profile preview

Shanghai Ginspire Biologics

Shanghai, Shanghai, Chinatobiopharm.com ↗
Ownership
Private
Employees
~18
Development stage
Other
01

Overview

Shanghai Ginspire Biologics is the early-research and discovery services arm of Thousand Oaks Biologics in Shanghai, operating through the legal entity Shanghai Jianshun Biosciences. The company focuses on early biologics R&D and provides integrated services spanning molecular design and optimization, antibody discovery and engineering, linker-payload screening, ADC construction, developability assessment, pharmacology evaluation, early sample preparation, and CMC-enabling work. Ginspire positions itself as a platform-based CRDMO/CRO partner for complex biologics including monoclonal antibodies, bispecific antibodies, fusion proteins, and antibody-drug conjugates. The business appears service-oriented rather than a traditional therapeutics developer, though it also states it may co-develop differentiated molecules and out-license self-developed assets. Its capabilities are supported by the broader Thousand Oaks Biologics manufacturing network in Nantong and Shanghai Lingang.

Therapeutic areas
ImmunologyOtherOncology
Modalities
Monoclonal antibodyBispecific monoclonal antibodyAntibody-drug conjugateRecombinant fusion proteinBiologic
Industry
Contract Research Organization

Beyond the preview

Go deeper on Shanghai Ginspire Biologics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai Ginspire Biologics.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call